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A B S T R A C T
Oxysterols are critical regulators of inflammation and cholesterol metabolism in cells. They are oxidation pro-
ducts of cholesterol and may be differentially metabolised in subcellular compartments and in biological fluids.
New analytical methods are needed to improve our understanding of oxysterol trafficking and the molecular
interplay between the cellular compartments required to maintain cholesterol/oxysterol homeostasis. Here we
describe a method for isolation of oxysterols using solid phase extraction and quantification by liquid chro-
matography-mass spectrometry, applied to tissue, cells and mitochondria.
We analysed five monohydroxysterols; 24(S)-hydroxycholesterol, 25-hydroxycholesterol, 27-hydro-
xycholesterol, 7α-hydroxycholesterol, 7 ketocholesterol and three dihydroxysterols 7α-24(S)dihydrox-
ycholesterol, 7α-25dihydroxycholesterol, 7α-27dihydroxycholesterol by LC-MS/MS following reverse phase
chromatography. Our new method, using Triton and DMSO extraction, shows improved extraction efficiency and
recovery of oxysterols from cellular matrix. We validated our method by reproducibly measuring oxysterols in
mouse brain tissue and showed that mice fed a high fat diet had significantly lower levels of 24S/25diOHC,
27diOHC and 7ketoOHC. We measured oxysterols in mitochondria from peripheral blood mononuclear cells and
highlight the importance of rapid cell isolation to minimise effects of handling and storage conditions on oxy-
sterol composition in clinical samples. In addition, in vitro cell culture systems, of THP-1 monocytes and neu-
ronal-like SH-SH5Y cells, showed mitochondrial-specific oxysterol metabolism and profiles were lineage specific.
In summary, we describe a robust and reproducible method validated for improved recovery, quantitative lin-
earity and detection, reproducibility and selectivity for cellular oxysterol analysis. This method enables sub-
cellular oxysterol metabolism to be monitored and is versatile in its application to various biological and clinical
samples.
1. Introduction
Oxysterols are biologically important molecules that regulate cell sig-
nalling, contribute to regulating cholesterol homeostasis and are essential
for bile acid and steroid hormone biosynthesis [1]. Oxysterols are formed
by oxidation and addition of hydroxyl groups onto cholesterol hydro-
carbon rings and side chains [2,3]. Enzymatic catalysed additions of hy-
droxyl to the side chain by cytochrome P450 (CYP) enzymes generate
mono- and di-hydroxysterols; 24(S)-hydroxycholesterol (24OHC), 25-hy-
droxycholesterol (25OHC), 27-hydroxycholesterol (27OHC), 20-hydro-
xycholesterol, 22-hydroxycholesterol, 7α-24(S)-dihydroxycholesterol
(24SdiOHC), 7α-25-dihydroxycholesterol (25diOHC) and 7α-27-
dihydroxycholesterol (27diOHC) [4]. Hydroxylation of the hydrocarbon
rings occurs by oxygen free radical attack forming hydroxylated sterols 7α-
hydroxycholesterol (7αOHC) and 7β-hydroxycholesterol, oxysterols with a
ketone group 7-ketocholesterol (7ketoOHC), epoxy cholesterols [5β, 6β-
epoxy cholesterol (5β, 6β-epox), 5α, 6α-epoxy cholesterol (5α, 6α-epox)
and cholestan-3β, 5α, 6β-triol [5,6].
The cellular localisation of enzymes responsible for oxysterol gen-
eration is critical to local oxysterol homeostasis [2]. In addition, the
redox states of subcellular compartments are different; the endoplasmic
reticulum (ER) has a strong reducing environment to enable protein
folding, whereas the mitochondria stores glutathione but is exposed to
greater potential for oxidation from reactive oxygen species (ROS)
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leakage by the electron transport chain, increasing the potential for
local cholesterol autoxidation [2]. Interaction between endosomes, ER,
mitochondria, cell membrane, peroxisomes and lysosomes is necessary
for cholesterol and oxysterol trafficking and sterol homeostasis in-
tracellularly; for instance, cholesterol is transported to mitochondria
from the ER either by direct membrane contact between ER and mi-
tochondria, or mobilised in lipid droplets (cholesterol esters) [7,8]. In
mitochondria, the steroidogenic acute regulatory protein (StAR)
transports cholesterol from the outer to inner membrane and controls
mitochondrial sterol trafficking [7,9]. Less is known about oxysterol
trafficking between the subcellular compartments [2].
Changes to oxysterol levels are implicated in the pathogenesis of
several diseases and targeting cholesterol and oxysterol dyshomeostasis
may provide a platform for development of novel therapeutics.
Dysregulation of cholesterol metabolism has been associated with me-
tabolic diseases such as cancer, heart and liver diseases and motor
neurone diseases [2,10,11].
Oxysterols are known to be cytotoxic at high concentration; accu-
mulation of 7-ketoOHC in lysosomes triggered membrane destabiliza-
tion and induced cell death in human monocytic U937 cells [12]. At a
subcellular level, accumulation of 7-ketoOHC and 7β-hydro-
xycholesterol by cholesterol autoxidation caused redox imbalance and
peroxisomal dysfunction in nerve cells [13,14]. Mitochondrial dys-
function and aberrant oxysterol metabolism have been recognized in
the pathogenesis of diseases such as atherosclerosis, carcinogenesis and
multiple neurodegenerative diseases including Alzheimer's disease
[15–20]. In vitro studies have shown that the addition of 7β-hydro-
xysitosterol and 7β-OHC induced loss of mitochondrial membrane po-
tential, membrane permeabilisation, oxidative stress and apoptosis in
human colon cancer, Caco-2 cells [21]. Again, high concentrations of
24OHC caused necroptosis in human neuroblastoma SH-SY5Y cells
whereas sublethal concentrations of 24OHC induced protection against
cytotoxic stress in these cells [22,23]. Similarly, accumulation of
25OHC has been shown to inhibit inflammasome activation in macro-
phages [24]. In neurodegenerative conditions, such as Alzheimer's
disease, oxysterol levels are linked to neuroinflammation, mitochon-
drial oxidative damage and cell death [25–27]. Thus, altered oxysterol
metabolism at both cellular and subcellular levels associates with al-
tered cell function and the pathogenesis of several chronic diseases. To
improve understanding of any contribution of oxysterols to disease and
in particular, to explore the mitochondria-oxysterol association and role
in disease, there is a need to reproducibly measure oxysterols in dif-
ferent subcellular compartments.
Oxysterols are ~10–1000 fold lower in abundance as compared to
cholesterol in cells and biological fluids [2,28]. The structural and
chemical properties of oxysterols are similar to each other and pose a
challenge in detection and quantification using analytical techniques
[2,29,30]. Analysis of oxysterols has been performed by both gas
chromatography-mass spectrometry and high performance liquid
chromatography-mass spectrometry (HPLC-MS) with the latter pro-
viding more sensitive targeted detection of sterols with the advanced
technique of multiple reaction monitoring (MRM) or MS/MS that tracks
precursor to product ion formation [31–33]. Oxysterol quantification
using LC-MS/MS has emerged as a popular analytical method, devel-
oped and adopted by many research groups. A number of methods have
been described to date for measuring oxysterols in human plasma,
serum, and cerebrospinal fluid, and these methods involve derivatisa-
tion of oxysterol moieties for subsequent quantifications [34–36]. Dias
et al., 2018, developed a multistep LC gradient for efficient direct MS
detection and quantification of oxysterols from human plasma reducing
the risk of artefactual oxidation during sample processing [29]. The
application of LC-MS methods for cellular oxysterol analysis is an
emerging field and has recently been applied in dietary intervention
studies [29,37,38], for example Beck et al., 2018 isolated and quanti-
fied oxysterols from carp cell lines, showing an increase in cellular
25diOHC after exogenous supplementation with 25OHC.
Oxysterol content also differs according to the cell type, tissue and
organism [2]. The different structural composition of discrete cells,
tissue and biological fluids requires that the methods for isolation of
lipids and oxysterols are tailored for the biological sample under study.
To date, no comprehensive method for oxysterol quantification at cel-
lular and subcellular levels has been reported. In this study, we describe
the isolation of mitochondria from whole cells, followed by isolation of
lipids and oxysterols from mitochondria. We adapted our LC-MS/MS
method for characterisation of mono and dihydroxycholesterols from
mitochondria.
Here we have compared our newly developed method to two pre-
viously published methods for extraction of lipids in mitochondrial
isolates from tissues by Bird et al., 2013 [38] and for measuring free
oxysterols in plasma by Dias et al., 2018 [29]. Our newly developed
method shows improved recovery, selectivity and highly sensitive de-
tection and quantification of oxysterols from discrete cellular com-
partments. Oxysterol distribution in whole cell and mitochondrial iso-
lates were profiled in THP-1 monocytes, SH-SY5Y neuroblastoma cell
and peripheral blood mononuclear cells (PBMC) isolated from whole
blood of healthy individuals. Our analysis showed differential oxysterol
distribution across cell types indicating cell and tissue specific oxysterol
metabolism. Furthermore, measurement of mitochondrial specific
oxysterol profile indicated local metabolism of oxysterols that was
distinct from the whole cell and endoplasmic reticulum. This method
enables quantification of oxysterols in mitochondria to elucidate com-
partment specific metabolism in clinical samples.
2. Materials and methods
2.1. Ethical statement for blood and mouse tissue samples
Blood samples were collected from healthy volunteers with ethics
committee approval and with informed consent.
The mouse experimental procedures were conducted under the
State Council of the People's Republic of China (Decree No. 2 of the
State Science and Technology Commission) October 31, 1988.
Amendment Regulations and approval of the local ethics committee for
use effective March 1, 2017. The experimental procedures in the
University of Surrey received ethical clearance under NASPA ethical
review assessment under reference number NERA-2017-011-Bio.
Effective date September 26, 2019.
2.2. PBMC isolation from blood
2.2.1. Blood samples
Blood samples were collected from healthy individuals and were
kept 1 h at room temperature or 24, 48 and 72 h at 4 °C. Whole blood
(10ml) was diluted 1:1 with RPMI + GlutaMAX, layered onto
Histopaque-1077 (Sigma) and centrifuged at 1000g for layer separa-
tion. The PBMC layer was retained, washed and resuspended in 9ml
STE buffer (250mM Sucrose, 5mM Tris and 2mM EGTA, pH7.4)/0.5%
BSA (purchased from Sigma Aldrich)).
2.3. Cell culture
The human monocytic THP-1 cell line (ATCC TIB-202) was grown in
RPMI 1640 medium supplemented with 10% heat inactivated fetal
bovine serum (FBS) at 37 °C, 5% CO2 and 95% humidity. Reagents were
purchased from Sigma Aldrich. SH-SY5Y cells were grown in Dulbecco's
modified Eagle's medium/F-12 with GlutaMAX supplemented with 10%
(v/v) foetal bovine serum, and penicillin (100U/ml) and streptomycin
(100μg/ml). Cell cultures were grown to 6 × 15cm plates at 80–90%
confluency and harvested through trypsinisation. The cell pellet was
washed in DMEM/F12 media before resuspending in STE/0.5% BSA
and proceeding with homogenisation and mitochondrial isolation as
described above for blood samples.
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2.4. Subcellular fractionation and mitochondrial isolation
SH-SY5Y cells (107 cells) were trypsinised and collected by cen-
trifugation at 1000g for 5 mins. PBMCs, THP-1 monocytes and SH-SY5Y
cells were washed with phosphate buffer saline prior to subcellular
fractionation and mitochondrial isolation using a method developed by
Kappler et al., 2016 [39]. Cells were re-suspended in 9ml STE +0.5%
BSA (250mM Sucrose, 5mM Tris and 2mM EGTA, pH7.4)/0.5% BSA)
buffer and placed on ice prior to homogenisation using a loose fitted
40ml Wheaton Dounce tissue grinder containing a further 9ml of buffer.
1ml of the cell homogenate was collected separately for whole cell (WC)
analysis with the remaining homogenate centrifuged at 1000g for 10
minutes at 4 °C, with pellets re-suspended and this step repeated. A
crude mitochondrial pellet was obtained by centrifugation of the su-
pernatant at 10,400g for 10 minutes at 4 °C. To gain a purer mi-
tochondrial fraction this pellet was resuspended in 200μl STE, layered
onto 25% Percoll gradient (25% Percoll (GE Healthcare), 25% 2xSTE
and 50% STE + 0.5% BSA) and ultracentrifuged at 80,000g for 20
minutes at 4 °C. The resultant ER/mitochondria and enriched mi-
tochondrial layers were extracted, washed with STE followed by PBS,
resuspended in molecular grade water and stored at −80 °C. For PBMCs
and SH-SY5Y cells, three fractions mitochondrial (M), ER/M and WC
were analysed. The following THP-1 monocyte subtractions, WC, M,
ER/M and WCR (remaining WC fraction pellet without M and ER/M,
obtained after first centrifugation step of the homogenate), were used
for method development and validations.
2.5. Western blot analysis of mitochondrial isolates
Protein quantification was performed using a Pierce bicinchoninic
acid protein assay kit (ThermoFisher), with electrophoresis using SDS-
PAGE and immunodetection using calnexin (Abcam, ab22595) and
ATP5A (Abcam, ab14748) followed by fluorescent DyLight secondary
antibodies (Invitrogen, SA5-10036 and 35519) and visualisation using a
CLx imaging system scanner (LI-COR Bioscience), using Geneflow
BLUeye protein ladder (245kDa) ladder (Supplementary Fig. 1).
2.6. High fat diet-fed mouse experiments and brain tissue sections
Four weeks old C57BL/6 male mice were maintained in Nanjing-
China SPF animal facility on a 07.00–19.00 day/light cycle at 20–22 °C
with food and water ad libitum. They were housed four in a cage and
fed either control (normal) diet or high fat diet (HFD) ad libitum for
four weeks. The body weight of the mice was taken every week. The
animals in HFD treated group were fed a 60% fat, 20% carbohydrate
and 20% protein per kcal% while the animals in the control group re-
ceived a 10% fat, 70% carbohydrate and 20% protein per kcal%. At the
end of their respective periods of feeding mice were culled through
cervical dislocation for tissue collection. Isolated serum was aliquoted,
snap frozen and stored at −80 °C freezer. Brains were removed, and
with systematic sampling, part of the tissues were snap frozen and
stored at −80 °C. Brain tissues (n = 5) from control and high fat diet
(HFD) mice were sectioned into ~50mg hemispheres, weighed and
used for lipid extraction.
2.7. Isolation of lipids from tissues, cell lines and blood PBMCs
Sample lysis: Mouse tissue (10–50mg) was weighed and re-sus-
pended in 70μl of 0.1% Triton X-100, 40μl dimethylsulfoxide (DMSO)
and 5 μl of butylatedhydroxytoluene (BHT) (90 mg ml−1) as an anti-
oxidant. Tissue sections were disrupted using a handheld rotor-stator
homogenizer TissueRuptor II for disruption of tissues sections. The
homogeniser probe was cleaned with ethanol/water- 30 seconds cycle
and tissue disruption was carried out for 30 seconds (until the material
homogenised), followed by cleaning of the probe. Whole cells (THP-1
monocytes, neuroblastoma SHY-5Y cell lines and blood PBMC),
mitochondria and endoplasmic reticulum/mitochondria fractions were
re-suspended in lysis buffer 70μl of 0.1% Triton X-100, 40μl DMSO and
5 μl of BHT (90 mg ml−1).
Homogenised tissue and cellular fractions were sonicated in the
lysis buffer for 20 minutes. Standards and quality controls were pre-
pared by adding a range of concentrations of each of the 9 authentic
oxysterols (0, 0.005, 0.010, 0.025, 0.050, 0.075, 0.1, 0.25, 0.5, 0.75
and 1ng.μl−1) within a mix into 30μl of whole cell lysate used as the
matrix, followed by addition of lysis buffer and sonication for 20
minutes. 3 μl of 22SOHC-D7 (50ng.μl−1) external standard was added
to the samples and standards and vortexed. Lipid extraction was carried
out in fume hood following the method of Bird et al., 2013, with
modifications adapted for this work. 190μl of LC-MS grade methanol
(MEOH) and 380μl of dichloromethane (DCM) were added to the
110μl− 1 sample lysates and standards and vortexed for 20 seconds.
120μl of LC-MS grade water was added to the samples and standards,
vortexed for 10 seconds and the tubes were allowed to stand at room
temperature for 10 minutes. Samples and standards were centrifuged at
7168g, 8 °C for 10 minutes. The upper and interphase phase of extract
was collected separately, dried and used for protein analysis. The lower
DCM layer ~350 μl with the lipid extract was collected separately and
dried under N2 gas using Turbovap LV purchased from Biotage. A
fraction of the lipid extract (15μl) was collected separately and dried for
cholesterol quantification.
2.8. Oxysterol extraction
The dried DCM lower phase was reconstituted in 500μl of MEOH
and 1.5ml of LC-MS grade water containing 0.1% formic acid and
mixed well. A vacuum manifold connected to a multichannel filtration
apparatus was used for the extraction of oxysterols. Oasis HLB solid
phase extraction (SPE) cartridges (Waters) were used for selective se-
paration of oxysterols from the lipid extracts. Cartridges were fitted into
the vacuum manifold and primed with 800μl MEOH and 600μl H2O +
0.1% formic acid. Samples were added slowly to the cartridges and the
flow through was discarded. Samples were washed with 600μl H2O +
0.1% formic acid and 600μl hexane to remove polar non-binding ana-
lytes and excess cholesterol. Butyl acetate (1ml) was added to the
cartridges and eluates were collected in a fresh tube with a controlled
flow of 1 drop per second. Butyl acetate eluates were dried under N2 gas
and reconstituted in 40μl of 40% MEOH containing 0.1% formic acid.
2.9. LC-MS/MS analysis
Standards (10μl) and samples (20μl) were injected into a NUCLE-
OSIL C18 column (100-5 125/2) fitted with a guard column for the
liquid chromatography (LC) analysis. Our previously developed solvent
composition in Dias et al., 2018 was used for separation of oxysterols.
Solvent A is 70% MEOH, 10% water, 0.1% formic acid and solvent B is
90% isopropanol, 10% MEOH and 0.1% formic acid. A multistep sol-
vent gradient was applied using ACQUITY Ultra performance liquid
chromatography (UPLC) quaternary system purchased from Waters.
The LC method used here was developed previously by Dias et al., 2018,
and was set to 0 minutes 16% B- 7 minutes 16% B; 7 minutes 16% B-11
minutes 24% B; 11 minutes 24%B-25 minutes 100%B; 25 minutes
100%B-30 minutes 100% B; 30 minutes 100% B- 32 minutes 16% B and
was held at 16% B up to 48 minutes. Mass spectrometry analysis was
performed using a Xevo TQ-S Triple Quadrupole Mass Spectrometer
(Waters) and operated with the positive electrospray ionisation (ESI)
mode. Nitrogen gas is used for desolvation at 500 °C and a flow rate of
900 L/hour−1 and collision gas argon at a flow rate of 0.15 ml/
minute−1 for collision. MRM transitions were set up using authentic
oxysterol standards (Avanti Polar) lipids. Standards include- 24(S) hy-
droxycholesterol (700061P), 25-hydroxycholesterol (700019P), 27-hy-
droxycholesterol (700021P), 7α-hydroxycholesterol (700034P), 7 ke-
tocholesterol (700015P), 7α,27-dihydroxycholesterol (700136P),
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7α,24 (R/S)-dihydroxycholesterol (700119P), 7α,25-dihydrox-
ycholesterol (700078P). The mass spectrometry method was set up with
the MRM transitions for 9 analytes using the Intellistart feature in Xevo
and are detailed in Table 1. The two best MRM transitions were iden-
tified for each analyte-the most abundant MRM as the quantifier and
the second most abundant was used as the qualifier. Authentic oxy-
sterols were dissolved in 50% methanol, 0.1% formic acid and working
stocks were prepared in a range of 10ng.μl−1 to 50ng.μl−1. Analytes
were infused directly into the MS system and transitions were de-
termined manually by inspection of the chemistry of the analyte and
optimisation of the ionisation parameters using the inbuilt Intellistart
feature of the Xevo TQs system. Infusions were performed at 10–20μl
min−1 and the cone voltage and collision energy were optimised in
order to obtain the 5 best MRM transitions. 7α,24Sdihydroxychoel-
sterol (24SdiOHC) and 7α,25Sdihydroxychoelsterol (25diOHC) had
identical MS/MS transitions and co-eluted with identical retention
times. So, these two analytes were analysed together as 24S25diOHC
for detection and quantification. For every batch of standards and
samples, an unprocessed standard mixture and pooled samples were
used as the quality control for the analyses.
2.10. Cholesterol and protein quantification
Cholesterol content in the lipid extract was quantified using the
Invitrogen™ Molecular Probes™ Amplex™ Red Cholesterol Assay Kit
(10236962) with 96 well plate assay set up that detects free and es-
terified cholesterol released from hydrolysis of cholesteryl esters.
Protein was quantified using Pierce Bichinchonic acid assay kit
(ThermoFisher) following the manufacturer's protocol. Fluorescence
(excitation-525 nm, emission- 585 nm) for Amplex™ Red cholesterol
assay kit and absorbance (562 nm) for BCA assay kit were measured
using SpectraMax i3x microplate reader and SoftMax Pro Software
(Molecular Devices). The lower limit of quantitation (LLOQ) for cho-
lesterol using the cholesterol assay kit and for protein were verified to
be 0.08ng.μl−1 and 5ng.μl−1 respectively.
2.11. Oxysterol quantification and data analysis
Mass spectrometry data was processed using MassLynx and
TargetLynx software (Waters). Oxysterols were identified by comparing
its retention time, exact mass, and MS/MS spectra to that of its au-
thentic standard. To check the extraction efficiency and recovery of
oxysterols from the cellular matrix, authentic standards were used.
Authentic standards were mixed with cellular lysate prior to oxysterol
extraction and LC-MS/MS analysis. A blank sample consisting of cell
lysate and no authentic standard added was analysed in parallel to
correct for interference from endogenous analytes. Peak Detection and
integration was performed with ApexTrack integration feature built in
MassLynx. ApexTrack integration automatically determines appropriate
integration parameters for peak width and threshold. Peak areas were
extracted for the quantifier MRM transition for each analyte. Standard
curves were generated using the authentic oxysterols with
concentrations 0, 0.005, 0.010, 0.025, 0.050, 0.075, 0.1, 0.25, 0.5, 0.75
and 1 ng μl−1. Linear regression analysis was done to derive the
equation for the line of best-fit and the concentration of oxysterols in
samples was calculated from this equation. The limit of quantification
(LOQ) was determined as per the US Food and Drug Administration
(FDA) and the European Medicines Agency (EMA) guidelines of LLOQ
defined as the lowest point on a calibration curve accepted based on an
analytical precision cut-off of a 20% relative standard deviation. The
lowest calibration curve point with co-efficient of variation< 20% was
evaluated from six independent measurements (two replicates for each)
done on different days was set as the LLOQ. Measurements below lower
limit of quantification (LLOQ) were assigned LLOQ/2 values, following
the models developed by Keizer et al., 2015 and Beal, 2001 to in-
corporate concentration data below the limit of quantification [40,41].
Graphs and statistical analysis including two-tailed student's t-tests,
ANOVA analysis and regression analysis were performed using
Graphpad prism 8.0 and in Microsoft excel. Principal component ana-
lysis (PCA) was performed using IBM SPSS statistical analysis software.
3. Results
3.1. Extraction and characterisation of oxysterols from whole cell and
mitochondria
Cellular/subcellular fractions were generated from THP-1 mono-
cytes, PBMC and SH-SH5Y neuroblastoma cells for investigation
(Fig. 1A). Fraction enrichment was confirmed by western blotting using
calnexin (ER) and ATP5A (mitochondrial) markers (Fig. S1). Next, we
isolated lipids and oxysterol pools from unfractionated whole cells and
subcellular fractions (Fig. 1B and C) with authentic standards in-
corporated into whole cell (WC) lysate to mimic the effect of a cellular
matrix, which may impair extraction efficiency. Eight authentic oxy-
sterol standards were used (Table 1) and 22S-hydroxycholesterol-d7
(22SOHCD7) as the external standard for setting up the LC-MS/MS
quantitation methodology (Fig. 1D).
The first extraction method M1, which had been established for
human plasma [29], involved protein precipitation with methanol fol-
lowed by oxysterol isolation using solid phase extraction (SPE) with
polymeric reversed-phase sorbent. We developed a MS/MS method
using a Waters Triple quad mass spectrometer to detect both mono and
dihydroxycholesterols using the MRMs in Table 1. MRMs were set up by
direct infusion of authentic standard into the mass spectrometer fol-
lowed by optimisation of cone voltage and collision energy to obtain
two best transitions for each of the nine oxysterols.
We employed our previously developed multistep gradient LC
method using a C18 reverse phase (RP) column [29] for chromato-
graphic separation of oxysterols (Fig. 1D). The three dihydroxysterols
analysed by our LC-MS/MS produced two chromatographic peaks each
due to their isomeric features (Supplementary Figs. S2A and B). The
two-peak feature was also observed with the 7α-dihydroxycholesterols
reported by others using LC analysis [42,43]. The first chromatographic
peak was the dominant one for the dihydroxycholesterols and as used in
Table 1
MRM transitions for oxysterols.
Analyte Quantifier transition Qualifier transition CV CE Retention time (min)
7α hydroxycholesterol 367.35 -> 147.42 367.35 -> 159.12 94 22, 22 18, 20.70
22(S)-hydroxycholesterol-d7 392.19 -> 159.11 392.19 -> 105.4 2 24, 44 15.15
7α,24(S)dihydroxycholesterol 383.11 -> 81.05 383.11 -> 105.03 38 30, 42 6.08, 10.20
7α,25dihydroxycholesterol 383.31 -> 81.05 383.31 -> 95.09 12 30, 30 6.04, 10.62
7α,27dihydroxycholesterol 401.43 -> 159.05 401.43 -> 81.06 40 24, 34 6.83, 11.97
24(S)hydroxycholesterol 367.35 -> 95.03 367.35 -> 147.09 12 30, 24 15.98
25 hydroxycholesterol 367.35 -> 147.09 367.35 -> 158.54 40 24,18 16.34
27 hydroxycholesterol 385.35 -> 81.06 385.35 -> 95.09 48 30,26 17.05
7-ketocholesterol 401.43 -> 95.05 401.43 -> 109.48 44 36, 34 18.75
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peak area analysis (Fig. S2A). The second peaks (peak 2) for
24S25diOHC and 27diOHC were 3/7th and 5/9th of the first peak re-
spectively. We chose the first dominant peak for quantification because
of the significantly larger peak area as compared to the second peak.
This choice avoids the risk of losing quantification because of the non-
detectability of the second peaks in samples with relatively low con-
centration of the dihydroxycholesterols.
3.2. Extraction efficiency and recovery of oxysterols from cellular matrix
Method M1 (our previously reported method for plasma) led to poor
chromatographic detection of oxysterol authentic standards within the
cellular matrix (Fig. 2A). The maximum recoveries for dihydroxysterols
and monohydroxysterols from the cellular matrix using M1 were 27%
and 9% respectively relative to the neat authentic standards analysed
Fig. 1. Methodology-work flow for isolation of lipids and oxysterols from cellular and subcellular compartments. Three cell types - THP-1 monocytes,
peripheral blood mononuclear cells (PBMC) and SH-SY5Y neuroblastoma cells-were used for this analysis. The work flow involves stage A - isolation of mitochondria
from whole cells, stage B - sample lysis and lipid extraction-cholesterol and protein measurements, stage C - oxysterol isolation using solid phase extraction (SPE)
followed by LC-MS/MS profiling using a multistep gradient of solvent A - 70% methanol (MeOH) + 30% H2O + 0.1% formic acid and solvent B - 90% isopropanol
(IPA) + 10% MeOH and 0.1% formic acid.
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without cellular matrix and SPE extraction (Fig. 2B). We next explored
method M2 for lipid extraction from rat liver tissues published in Bird
et al., 2013 [38]. This method involved isolation of lipid pools fol-
lowing cell lysis in dimethylsulfoxide (DMSO), followed extraction of
lipids by methanol (MeOH):dichloromethane (DCM) (1:2) solvent ex-
traction. We extracted oxysterols from the total lipids using a solid
phase extraction (SPE) separation technique as described in Dias et al.,
2018. M2 also gave poor recovery of oxysterol standards as seen from
chromatograms (Fig. 2C). M2 gave a maximum of 48% for dihydrox-
ysterols and 21% for monohydroxysterols (Fig. 2C). We speculated the
poor recovery of oxysterols was due to the incomplete cell lysis and
poor lipid extraction. Method M3 yielded well resolved oxysterol peaks
and improved chromatographic separation (Fig. 2A). We used 0.1%
Triton X-100 and DMSO as detergents and BHT as an antioxidant during
cell lysis. LC-MS/MS analysis showed enhanced recovery of both mono
and dihydroxysterols standards in WC matrix using the Triton cell lysis
method (M3) (Fig. 2A and D, Fig. S2B). The recoveries of both mono
and dihydroxycholesterols ranged from 74 to 100%.
3.3. Method validation for subcellular oxysterol quantitation
We used method M3 to generate standard curves with authentic
oxysterols mixed in WC lysates in concentrations ranging from 5 pg.
μl−1 to 1 ng μl−1. Regression analysis produced an R2 ≥ 0.9 for all
oxysterols confirming linearity between concentration of an analyte
and its peak area (Fig. 3A). The co-efficient of variation (CV) between
the standard concentrations measured intra and inter days was calcu-
lated. The lower limit quantification (LLOQ) was set up with the lowest
standard measurements that had a CV of< 20% across intra- and inter-
day measurements (Fig. 3B). Precision of the standard curves were
monitored with quality control (QC) samples consisting of eight oxy-
sterols that showed a CV of ≤20%. THP-1 monocytes were used to set
Fig. 2. Comparison of oxysterol recovery and matrix effects from three methods. (A) Three methods; M1 (methanol (MeOH) cell lysis and SPE oxysterol
extraction, M2 dimethylsulfoxide (DMSO) cell lysis, methanol:dichloromethane (MeOH:DCM) lipid isolation and SPE oxysterol extraction, M3 (0.1% Triton X-
100 + DMSO cell lysis, MeOH:DCM lipid extraction and SPE oxysterol extraction) were compared. Authentic standards were prepared in 40% methanol 0.1% formic
acid (without cellular matrix and no SPE extraction) and used as the control (black bars). M3 improved chromatographic resolution of 10ng authentic oxysterol
standards mixed with whole cell lysate as the matrix and isolated using the methodology described in Fig. 1 (B), (C) and (D) compares the recovery (ratio of +SPE
peak area/No SPE peak area) expressed as % for the authentic standards in matrix using extraction methods M1 [29], M2 [38] and M3-developed in this work. M3
showed>70% recovery for all nine oxysterols. Measurements were done using standards at 1ng.μl-1 and are mean ± S.D. of 3–4 independent replicates.
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up the quantitation and for reproducibility analysis. Fig. 3C compares
the chromatographic resolution of oxysterols from THP-1 monocytes
using the three methods. Method M3 showed the highest extraction
efficiency of oxysterols. We then checked the linearity of the LC-MS/MS
method by quantifying oxysterols from THP-1 monocytes with varying
cell numbers. We used 105, 106 and 107 THP-1 cells as the starting
material for extraction and quantification of oxysterols, cholesterol and
protein (Fig. 3D and E, Supplementary Fig. S3). There were linear re-
lationships between the number of monocytes used as the starting
material, and monohydroxycholesterol, cholesterol and protein con-
centrations, implying 105 monocytes was the lower acceptable limit of
starting material for detection of monohydroxycholesterols (Fig. 3E).
However, 105 monocytes were insufficient for detection of dihydrox-
ycholesterols (Fig. 3E). The limit of starting material for quantification
of the three dihydroxycholesterols analysed here was 106 monocytes.
We tested the reproducibility of oxysterol extraction and quantifi-
cation in subcellular fractions - mitochondria (M), endoplasmic re-
ticulum/mitochondria (ER/M) and remaining cell lysate (WCR)
(Fig. 3F). Cellular fractions from 107 THP-1 monocytes were isolated on
the same day and stored for two different lengths of time at −80 °C,
from one to seven days prior to oxysterol extraction and LC-MS/MS
analysis. The amounts of oxysterol were normalised to the cholesterol
Fig. 3. Method validation for oxysterol quantification in THP1 subcellular fractions. (A) Standard curve and R2 goodness-of-fit of the curve for oxysterol
standards produced using method M3. (B) Co-efficient of variation of standard curve and identification of lower limit of quantification (LLOQ) and upper limit of
quantification (ULOQ). LC injections for the standards were 10μl and the values are mean ± S.D. of 3–4 independent extractions and LC-MS/MS analysis. (C)
Chromatographic resolution of oxysterols extracted from THP-1 monocytes using the methods M1, M2 and M3. (D) Chromatography of mono and dihydrox-
ycholesterols from monocytes ranging from 105 to 107. (E) Quantification of oxysterols, cholesterol and protein in THP-1 monocytes and their linearity with number
of cells used for extraction and LC-MS/MS analysis. # indicates the amount detected was close to the LLOQ and are unreliable measurements. (F) Reproducibility
analysis of oxysterol extraction and quantitation. Data shown are mean ± S.D. of biological replicates (n = 3–5). Student's t-test (cut off *, p ≤ 0.05) was used to
check statistically significant differences in the measurements (absolute and log transformed); ns denotes not significant.
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quantified for each subfraction (Fig. 1). Cholesterol quantitation was
performed using fluorometric cholesterol red assay and the LLOQ was
verified to be 0.08 ng μl−1. There were no statistically significant dif-
ferences between the measurements of oxysterols and cholesterol after
seven days of storage at −80 °C (Fig. 3F, Supplementary Fig. S4). The
amounts of 25OHC and 7ketoOHC, the sterols that can also be gener-
ated by cholesterol autoxidation, did not vary significantly between
Day 1 and Day 7 indicating negligible autoxidation under the storage
conditions for fractionated cells in the presence of BHT and at −80 °C.
The data from Day 1 and Day 7 also confirms the inter day precision of
oxysterol extraction and LC-MS/MS analysis of samples fractionated
and stored for up to one week.
3.4. Application of the method to characterise tissue oxysterols
We applied our optimised method M3 for oxysterol extraction and
quantitation in tissues including mouse brain and whole blood (Fig. 4).
We quantified oxysterols normalised to cholesterol in brains from two
groups of mice, one fed on normal chow and one on high fat diet to
validate the method (Fig. 4A). We show 24SOHC as the most abundant
oxysterol in the brain tissues of both groups of mice, consistent with
previous observations [43,44] (Supplementary Fig. S5A). Our data
shows 27OHC, 25OHC and 27diOHC as the next most abundant oxy-
sterols, with levels at least 10-fold lower concentrations than 24SOHC
(Supplementary Fig. S5A). The monohydroxysterol, 24SOHC, was also
the most abundant sterol in high fat diet mice although the corrected
levels of 24SOHC were reduced four fold from 6108.6 ± 2535 ng μg−1
cholesterol in normal diet fed mice to 1512 ± 251 ng μg−1 cholesterol
in high fat diet mice (Fig. 4A). The brain levels of all oxysterols were
lower in high fat diet fed mice with significant decreases in levels of
24S25diOHC, 27diOHC and 7ketoOHC (Fig. 4A). This was not ex-
plained simply by the correction used for the elevated cholesterol levels
in high fed diet mouse brain (twofold higher than that of the normal
diet fed mice) (Fig. 4B). The analysis here established the versatility and
applicability of the method to extract and quantify oxysterol from tissue
sections and the biologically relevant and reproducible oxysterol dis-
tributions obtained from mouse brain.
We applied our method to measure oxysterol profiles in whole blood
PBMCs and their mitochondrial subfractions to validate the applic-
ability of this method to clinical samples. Blood samples were collected
from healthy individuals and were stored under four different condi-
tions- 1h at room temperature, 24h at 4 °C, 48h at 4 °C and 72h at 4 °C
prior to PBMC and subsequent mitochondrial isolation. This analysis
was used to determine optimal storage conditions for blood samples
and to determine whether the various storage and handling conditions
introduced variations in the subsequent subcellular oxysterol mea-
surements. Oxysterols were extracted from whole PBMCs and mi-
tochondria harvested from blood stored under the four aforementioned
conditions and compared to analyse the effect of storage times on
oxysterols. Fig. 4C shows that the protein and cholesterol content in
Fig. 4. Oxysterol profiles in tissues. (A) Oxysterol profiles in brain tissues of mice fed with normal chow diet vs. high fat diet. Statistical significance was calculated
using paired t-test (two-tailed) with α = 0.05; *, P < 0.05. (B) Cholesterol levels in brain tissues of mice fed with normal chow diet vs. high fat diet. Values are
mean ± S. D (n = 5). (C) Cholesterol and protein levels in the mitochondria and whole peripheral blood mononuclear (PBMC). (D) Changes in oxysterol levels of
mitochondria isolated from blood stored under various conditions. Values are mean ± S.D. (n = 2 to 5). ANOVA analysis and statistical test using Holm-Sidak
method, with α = 0.05 without assuming a consistent S. D were performed to check for statistically significant differences in mitochondrial oxysterols isolated from
blood stored under the four storage periods- 1 hour/room temperature, 24 hour/4 °C, 48 hour/4 °C and 72 hour/4 °C.
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mitochondria and whole PBMC were not affected by storage, however,
we observed a trend for increase in the 7ketoOHC profiles in the mi-
tochondrial fraction with the increase in blood storage period (up to 12-
fold; Fig. 4D), suggesting that cholesterol autoxidation occurs in mi-
tochondria fractionated from blood leukocytes with increased storage
times. This trend of 7ketoOHC accumulation was not observed in whole
PBMCs isolated from stored blood (Supplementary Fig. S5B). Also, we
did not observe such change in the protein and cholesterol measure-
ments, indicative of the small contribution of oxysterols to total cho-
lesterol.
The analysis here shows variations in subcellular oxysterol levels as
a consequence of the experimental conditions used prior to oxysterol
extraction, and that these variations were captured by the quantitation
method developed in this study. The analysis highlights the importance
of a standardised storage condition for analysis of clinical samples to
minimise autoxidation. The analysis also showed differential oxysterol
metabolism in brain and blood tissues. Unlike brain tissues, for which
24SOHC was the abundant sterol, in PBMC mitochondrial fractions and
PBMCs, 27OHC and 7ketoOHC were the most abundant oxysterols in-
dicating differences in oxysterol metabolism between tissues
(Supplementary Fig. S5C).
3.5. Application of the method to profile mitochondrial oxysterols of cell
lines
The optimised method M3 was applied to measure oxysterol profiles
in mitochondria, ER/mitochondrial and whole cell fractions of SH-SY5Y
cells. We compared the mitochondrial and whole cell oxysterol profiles
of SH-SY5Y to that of THP-1 monocytic cell lines and PBMCs in order to
capture cell lineage specific differences. Fig. 5A and B shows principal
component analysis (PCA) plots of SH-SY5Y vs. PBMC and SH-SY5Y vs.
THP-1 oxysterols respectively. The oxysterol component profiles of SH-
SY5Y were grouped distinctly to that of PBMC and THP-1s respectively.
The differences were pronounced in the mitochondrial and whole cell
profiles of SH-SY5Y vs. THP-1 (Fig. 5B). In particular, the levels of
24S25diOHC, 27diOHC and 7ketoOHC were higher in THP-1 mi-
tochondrial fractions than the SH-SY5Y mitochondrial fractions
(Fig. 5C). In whole THP-1 monocytes, 27diOHC and 24SOHC were
higher than that measured in SH-SY5Y cells (Fig. 5D). These analysis
shows cell specific oxysterol metabolism with distinct mitochondrial
profiles in the two cell types. We compared THP-1 profiles to that of
PBMCs by PCA and show distinct grouping of the mitochondrial and
whole cell oxysterol profiles from THP-1 monocytes (Fig. S6A).
We next explored compartment specific oxysterol metabolism from
whole cell (WC), mitochondria (M) and endoplasmic reticulum/mi-
tochondria (ER/M) fractions of SH-SY5Y cells. The levels of total cho-
lesterol were lower in M and ER/M fractions and oxysterol distributions
were distinct in the subcellular compartments (Figs. S6B and 5E). For
instance, 27OHC concentrations were significantly higher than the
other enzymatically derived mono- and di-hydroxycholesterols in mi-
tochondria, while 7ketocholesterol was the dominant oxysterol in ER/
M and WC fractions. 24SOHC was the least abundant oxysterol in mi-
tochondria, while 24S25diOHC were the least abundant in ER/M and
WC. The overall mitochondrial oxysterol concentrations were lower
than in ER/M and WC fractions.
Compartment-specific oxysterol profiles were also determined in
THP-1 monocytes and 7ketoOHC was the predominant oxysterol in M
and WC fractions (Fig. S6C). Unlike in SH-SY5Y cells, where the overall
mitochondrial oxysterol concentrations were lower than in ER/M and
WC fractions, the oxysterol levels in the three compartments of THP-1
monocytes were comparable albeit the levels of cholesterol in M and
ER/M fractions were over tenfold lower than that in the WC (Fig. S6D).
These analyses confirm that oxysterol profiles are distinct between
mitochondria, endoplasmic reticulum/mitochondria and whole cells,
confirming compartment specific oxysterol metabolism in cells.
4. Discussion
Recent advances in high throughput analytical techniques have
enabled measurement of oxysterols in various biological systems
[16,32,45]. Our newly developed method allowed simultaneous de-
tection of mono and dihydroxycholesterols across mouse brain tissues,
cell lines and blood samples, providing a versatile method that can be
applied to various biological samples.
Extraction efficiency and recovery of oxysterols from cells and tis-
sues without artefactual oxidation is critical for quantitation, because
endogenous sterols are present in trace amounts in cells and tissues
(Dias et al., 2018). Here we used authenticated standards to confirm the
extraction efficiency/recovery, which was ≥74% for the nine sterols
including the external standard. The use of surrogate heavy stable
isotope-labelled standards offers an additional advantage to check and
correct for the chromatographic shifts in the peak width and retention
times for endogenous analytes. They may be evaluated to replace the
external deuterated standard and used for quantitation if they have
identical recovery and matrix effects as the analyte of interest. Our
previously developed method (Dias et al., 2018) was successfully em-
ployed to quantify monohydroxycholesterols in plasma [29]. Although
this method allowed>80% recovery of sterols from a plasma matrix, it
failed to provide similar recovery of sterols from a cell matrix, con-
firming the essential requirement to tailor methods for optimal oxy-
sterol extraction efficiency in cells and tissues. Eukaryotic cells are
highly compartmentalised systems with cholesterol and oxysterol me-
tabolism localised in specific subcellular compartments [2,46]. There-
fore, complete cell lysis and release of oxysterol pools from the cellular
niche has required a new rigorous method, as developed in this study,
using Triton X-100 for efficient extraction.
Autoxidation of cholesterol during sample processing is a critical
factor to account for during sterol analysis [29,47]. Use of antioxidants
and also an initial separation step to remove cholesterol is adopted to
minimise risk of autoxidation artefacts. Use of SPE columns for cho-
lesterol removal is a widely accepted oxysterol selective technique that
was also included in our method [29,30]. A previous study reported the
use of SPE silica columns to cause a 1–3% cholesterol autooxidation to
5/6 (α/β)-epoxycholesterol [32]; however, the effect of such oxidation
and biological interference was shown to be minimal in our previous
study [29]. Also, our current method did not result in any change to
oxysterol levels particularly in 7ketoOHC that could be generated by
autoxidation from cholesterol during sample storage, handling and
extraction process if the cells were stored intact. The extraction and
quantitation performed on two different days for THP-1 cells did not
lead to any significant variation in subcellular oxysterol distribution.
However, blood stored under four different conditions (time and
temperature) prior to PBMC harvest and cellular fractionation, in-
troduced biological variation, including increased cholesterol auto-
xidation to 7ketoOHC particularly in mitochondria. The effects of
processing and handling on clinical specimens have already been re-
cognized and evaluated for serum and plasma samples where standar-
dized procedures are advised to avoid confounding factors and bias for
validation studies and biomarker discoveries [48]. Following from our
analysis, we stress the practice of uniform clinical sample handling and
minimal blood storage time to avoid autoxidation artefacts that may
arise e.g. from mitochondrial oxidative stress during storage that was
measured here as mitochondrial 7ketoOHC and which was not present
in whole cell PBMCs.
The choice of solvent compositions for HPLC sterol analysis affects
the signal intensity. Acetonitrile as a mobile phase has negative effects
on the electrospray ionisation process and reduction in signal intensity
of oxysterols due to adduct formations [32]. Solvent compositions of
methanol/water are preferably and widely used for LC oxysterol ana-
lyses [3,32,49]. In our method we used a multistep gradient composed
of methanol/water/isopropanol that allowed baseline separation of the
monohydroxycholesterols and in particular, separation of the two
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Fig. 5. Oxysterol profiles in different cell types. (A) Principal component analysis (PCA) of mitochondrial and whole cell oxysterol measurements of SH-SY5Y
neuroblastoma cells vs. blood PBMCs. (B) PCA of mitochondrial and whole cell oxysterol measurements of SH-SY5Y vs. THP-1 monocytes. (C) Mitochondrial
oxysterol levels and (D) Whole cell oxysterol levels in SH-SY5Y and THP-1. E, Compartment specific oxysterol profiles in SH-SY5Y. Values are mean ± S.D. (n = 3).
Values are mean ± S.D. (n = 3). Statistical significance calculated by unpaired t-test Welch's correction (two-tailed) on log data, ns, not significant, *p < 0.05,
**P < 0.005, ***P < 0.0005.
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critical oxysterols- 24SOHC and 25OHC [29]. A limitation of existing
LC methods is the co-elution of the two dihydroxycholesterols-
24SdiOHC and 25diOHC. These two are difficult to resolve by LC and
also by MS/MS because of their identical MRM transitions. The two
dihydroxycholesterols could not be separately resolved on the C-18
reverse phase, because of the weaker interaction between these ana-
lytes and the column bed. In the future, the baseline resolution of these
dihydroxycholesterols may be improved by new alternate column
chemistry.
We evaluated the biological validity of our method for oxysterol
analysis by measuring oxysterol profiles from mouse brain sections. In
alignment with other studies by Griffiths and Wang, 2009 [31], our
method also identified 24SOHC as the most abundant oxysterol in
mouse brain. Our results also showed significant decrease in
24S25diOHC, 27diOHC and 7ketoOHC levels after an increase in
dietary fat intake. Lower concentrations of dihydroxysterols may be
indicative of cholesterol accumulation in the ER, leading to ER stress
and impaired activity of specific ER cholesterol metabolising enzymes
such as Cyp7b1 [50]. Previous studies have described the association
between increased dietary cholesterol and dementia [51], and others
have shown a decrease in 24SOHC and increase an in 27OHC and
7ketoOHC in post-mortem brains of patients with advanced dementia
[52]. A different study evaluated the effects of high fat diet on hy-
pothalamic oxysterols in C57BL/6 mice, showing high plasma choles-
terol, no significant modifications 24SOHC and 27OHC and a decrease
in the levels of 7ketoOHC consistent with our oxysterol measurements
from brain tissues of high fat diet fed mice [53]. Guillemot-Legris et al.,
2015 also showed significant modifications in hepatic, plasma and
adipose tissue oxysterols, 4βhydroxycholesterol, 25OHC and 27OHC in
a time course dependent manner. Sozen et al., 2018 also evaluated the
effects of high cholesterol diet on fatty acid, oxysterol and scavenger
receptor levels in heart tissues of rabbits, and showed both cholesterol
and oxysterols including 4βhydroxycholesterol, 25OHC, 27OHC and
7ketoOHC levels were elevated in heart tissues of high cholesterol fed
animals [54]. Taken together the findings from this study and the
previous research suggests that the high fat dietary effects on oxysterol
accumulation are tissue dependent.
Biosynthesis and metabolism of oxysterols is distinctive within
subcellular compartments with Cyp27A1 (mitochondrial specific sterol
27 hydroxylase) functions in the acidic pathway of bile acid synthesis
and catalyses 27 hydroxylation of cholesterol to produce 27OHC
(Fig. 6) [55,56] and is expressed exclusively in mitochondria. However,
whereas Cyp7b1, Cyp46A1 and Cyp39A1 are more prevalent in the ER
[2,56,57] (Fig. 6). We measured compartment specific oxysterol pro-
files in SH-SY5Y and THP-1 cell lines, of neural and myeloid origin
respectively [58,59], and showed markedly different oxysterol dis-
tribution between two cell models, particularly in the mitochondrial
subfractions of the cells. A previous study adopted a radioisotopically
labelled approach to trace oxysterol formation in THP1 cells [60]. After
addition of labelled cholesterol, between 10-20% was converted to
oxysterols within 24 hours. Here, we also measured a similar propor-
tion of oxysterol to cholesterol in THP-1 monocytes but not in SH-SY5Y
cells. Considering both THP-1 and SH-SY5Y are cancer cells and that
they have a dominant glycolytic metabolism [60,61], our analyses
shows that independent of this, oxysterol metabolism is significantly
distinct in the mitochondrial fractions of these cells.
After the autoxidised oxysterol 7ketoOHC, 27OHC was the abun-
dant enzymatically produced oxysterol in SH-SY5Y mitochondrial
fractions confirming the mitochondrial activity of sterol 27-hydro-
xylase, and this is consistent with previous findings [2,56,57]. The le-
vels of cholesterol were lower in the endoplasmic reticulum and mi-
tochondrial fractions than the whole cells of both THP-1 monocytes and
SH-SY5Y cells. Plasma membrane contains majority of cholesterol at
cellular levels and this explains the minimal amount of cholesterol
measured in THP-1 and SH-SY5Y subfractions and that majority of
cholesterol is retained in the membrane fractions of these cells [61,62].
Despite the minimal cholesterol levels in the mitochondrial fractions,
the oxysterol levels were comparable to that of the whole cells, parti-
cularly in the THP-1 monocytes. This highlights mitochondria as one of
the primary cellular compartment housing significant oxysterol meta-
bolism at the cellular level.
In summary, we have developed a robust, a highly sensitive and
Fig. 6. Cholesterol-oxysterol metabolic pathway. Cholesterol is converted to bile acids by classical and acidic pathway. Enzymes specific to mitochondria and
endoplasmic reticulum are colour coded. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
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selective method for extraction and quantification of oxysterols from
mitochondria. We show the application of our method to identify mi-
tochondrial specific oxysterol metabolism in different cell lines in-
cluding SH-SY5Y, PBMC and THP-1. The method offers versatility in its
application to tissue sections, cell lines and blood leukocytes for pro-
filing the oxysterol distribution and in particular, to study cholesterol/
oxysterol metabolism in the context of disease.
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